Cargando…
Macular cutaneous amyloidosis treated with methyl aminolevulinate and daylight photodynamic therapy: A case report
Primary cutaneous amyloidosis is characterized by polymerization of extracellular amyloid precursors in β-pleated sheet conformation into larger fibrillar aggregates. Observation in models of Alzheimer’s disease have noted that amyloid polymerization in the brain is blocked by reactive oxygen specie...
Autores principales: | Huang, Christina M, Lam, Lauren, Gniadecki, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378484/ https://www.ncbi.nlm.nih.gov/pubmed/30800310 http://dx.doi.org/10.1177/2050313X19829617 |
Ejemplares similares
-
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia
por: See, Jo‐Ann, et al.
Publicado: (2015) -
Fully home‐based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study
por: García‐Gil, Miguel Fernando, et al.
Publicado: (2022) -
Daylight Photodynamic Therapy: An Update
por: Lee, Chaw-Ning, et al.
Publicado: (2020) -
Equivalent efficacy of indoor daylight and lamp‐based 5‐aminolevulinic acid photodynamic therapy for treatment of actinic keratosis
por: Ruiz, Alberto J., et al.
Publicado: (2023) -
Measuring Daylight: A Review of Dosimetry in Daylight Photodynamic Therapy
por: O’Mahoney, Paul, et al.
Publicado: (2019)